Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population.

NCT01433120 is registered in ClinicalTrials.gov with University of Copenhagen as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01433120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population.
Lead sponsor
University of Copenhagen
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2011
Completion date
August 31, 2013
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.